Dautphetal, Germany

Achim Becker

This inventor holds 2 USPTO granted patents. Top assignee: Behringwerke Aktiengesellschaft. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Achim Becker. Retrieved from https://idiyas.com/inventor/achim-becker-yc7smfoi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Achim Becker: Innovator in Antithrombin Research

Introduction

Achim Becker is a notable inventor based in Dautphetal, Germany. He has made significant contributions to the field of biochemistry, particularly in the study of human antithrombin III. With a total of 2 patents, his work has implications for medical advancements and therapeutic applications.

Latest Patents

Becker's latest patents focus on mutants of human antithrombin III and methods for their production. These patents describe mutants of antithrombin III that have been advantageously modified at one or more potential glycosylation sites or at the Arg393 position. The combination of these mutations typically enhances the advantageous modifications, showcasing his innovative approach to biochemistry.

Career Highlights

Achim Becker is associated with Behringwerke Aktiengesellschaft, a company known for its contributions to the pharmaceutical industry. His work at this institution has allowed him to explore and develop his research in antithrombin III, leading to his patented innovations.

Collaborations

Throughout his career, Becker has collaborated with esteemed colleagues such as Gerd Zettlmeissl and Hermann Erich Karges. These partnerships have likely enriched his research and contributed to the success of his projects.

Conclusion

Achim Becker's contributions to the field of biochemistry, particularly through his patents on antithrombin III, highlight his role as an innovator. His work continues to influence medical research and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…